Literature DB >> 32822703

Kidney-intrinsic factors determine the severity of ischemia/reperfusion injury in a mouse model of delayed graft function.

Longhui Qiu1, Xingqiang Lai2, Jiao-Jing Wang1, Xin Yi Yeap1, Shulin Han1, Feibo Zheng1, Charlie Lin3, Zhuoli Zhang4, Daniele Procissi4, Deyu Fang5, Lin Li6, Edward B Thorp5, Michael M Abecassis7, Yashpal S Kanwar8, Zheng J Zhang9.   

Abstract

Delayed graft function due to transplant ischemia/reperfusion injury adversely affects up to 50% of deceased-donor kidney transplant recipients. However, key factors contributing to the severity of ischemia/reperfusion injury remain unclear. Here, using a clinically relevant mouse model of delayed graft function, we demonstrated that donor genetic background and kidney-intrinsic MyD88/Trif-dependent innate immunity were key determinants of delayed graft function. Functional deterioration of kidney grafts directly corresponded with the duration of cold ischemia time. The graft dysfunction became irreversible after cold ischemia time exceeded six hours. When cold ischemia time reached four hours, kidney grafts displayed histological features reflective of delayed graft function seen in clinical kidney transplantation. Notably, kidneys of B6 mice exhibited significantly more severe histological and functional impairment than kidneys of C3H or BALB/c mice, regardless of recipient strains or alloreactivities. Furthermore, allografts of B6 mice also showed an upregulation of IL-6, neutrophil gelatinase-associated lipocalin, and endoplasmic reticulum stress genes, as well as an increased influx of host neutrophils and memory CD8 T-cells. In contrast, donor MyD88/Trif deficiency inhibited neutrophil influx and decreased the expression of IL-6 and endoplasmic reticulum stress genes, along with improved graft function and prolonged allograft survival. Thus, kidney-intrinsic factors involving genetic characteristics and innate immunity serve as critical determinants of the severity of delayed graft function. This preclinical murine model allows for further investigations of the mechanisms underlying delayed graft function.
Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  delayed graft function; donor factors; innate immunity; ischemia/reperfusion injury; kidney transplantation; mouse model

Mesh:

Year:  2020        PMID: 32822703      PMCID: PMC7814505          DOI: 10.1016/j.kint.2020.07.033

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  84 in total

1.  Protective Effects of L-Carnitine Against Delayed Graft Function in Kidney Transplant Recipients: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.

Authors:  Atefeh Jafari; Mohammad-Reza Khatami; Simin Dashti-Khavidaki; Mahboob Lessan-Pezeshki; Alireza Abdollahi; Azadeh Moghaddas
Journal:  J Ren Nutr       Date:  2017-01-04       Impact factor: 3.655

2.  Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial.

Authors:  Kalathil K Sureshkumar; Sabiha M Hussain; Tina Y Ko; Ngoc L Thai; Richard J Marcus
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 8.237

3.  Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection.

Authors:  Nadine M Lerret; Ting Li; Jiao-Jing Wang; Hee-Kap Kang; Sheng Wang; Xueqiong Wang; Chunfa Jie; Yashpal S Kanwar; Michael M Abecassis; Xunrong Luo; Zheng Zhang
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

4.  Genetic susceptibility to renal ischemia reperfusion injury revealed in a murine model.

Authors:  M J Burne; M Haq; H Matsuse; S Mohapatra; H Rabb
Journal:  Transplantation       Date:  2000-03-15       Impact factor: 4.939

5.  A prospective randomized, controlled trial of eculizumab to prevent ischemia-reperfusion injury in pediatric kidney transplantation.

Authors:  Michael Kaabak; Nadeen Babenko; Ron Shapiro; Allan Zokoyev; Olga Dymova; Edward Kim
Journal:  Pediatr Transplant       Date:  2018-01-29

6.  Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function.

Authors:  Claus U Niemann; John Feiner; Sharon Swain; Scott Bunting; Melissa Friedman; Megan Crutchfield; Kristine Broglio; Ryutaro Hirose; John P Roberts; Darren Malinoski
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245

7.  IL-6/IL-6R axis plays a critical role in acute kidney injury.

Authors:  Yael Nechemia-Arbely; Daniel Barkan; Galina Pizov; Anat Shriki; Stefan Rose-John; Eithan Galun; Jonathan H Axelrod
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

8.  Macrophage-derived IL-6 contributes to ANG II-mediated angiotensinogen stimulation in renal proximal tubular cells.

Authors:  Ryan O'Leary; Harrison Penrose; Kayoko Miyata; Ryousuke Satou
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-23

Review 9.  Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update.

Authors:  Hua Su; Chun-Tao Lei; Chun Zhang
Journal:  Front Immunol       Date:  2017-04-21       Impact factor: 7.561

10.  Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding.

Authors:  Nemanja Jovicic; Ilija Jeftic; Ivan Jovanovic; Gordana Radosavljevic; Nebojsa Arsenijevic; Miodrag L Lukic; Nada Pejnovic
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

View more
  3 in total

1.  Cell stress response impairs de novo NAD+ biosynthesis in the kidney.

Authors:  Yohan Bignon; Anna Rinaldi; Zahia Nadour; Virginie Poindessous; Ivan Nemazanyy; Olivia Lenoir; Baptiste Fohlen; Pierre Weill-Raynal; Alexandre Hertig; Alexandre Karras; Pierre Galichon; Maarten Naesens; Dany Anglicheau; Pietro E Cippà; Nicolas Pallet
Journal:  JCI Insight       Date:  2022-01-11

2.  CLCF1 is up-regulated in renal ischemia reperfusion injury and may associate with FOXO3.

Authors:  Sixu Wang; Xinyi Hu; Linlin Ma; Lei Zhang; Ye Tian
Journal:  Ann Transl Med       Date:  2022-04

3.  Prevention of vascular-allograft rejection by protecting the endothelial glycocalyx with immunosuppressive polymers.

Authors:  Erika M J Siren; Haiming D Luo; Franklin Tam; Ashani Montgomery; Winnie Enns; Haisle Moon; Lyann Sim; Kevin Rey; Qiunong Guan; Jiao-Jing Wang; Christine M Wardell; Mahdis Monajemi; Majid Mojibian; Megan K Levings; Zheng J Zhang; Caigan Du; Stephen G Withers; Jonathan C Choy; Jayachandran N Kizhakkedathu
Journal:  Nat Biomed Eng       Date:  2021-08-09       Impact factor: 25.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.